Tailoring Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer: Recent Advances and Strategies
Francisco J. Esteva, Elena Katz
Abstract
Neoadjuvant HER2 Therapy: Beyond one-size-fits-all.
Topics & Concepts
Human Epidermal Growth Factor Receptor 2Breast cancerOncologyNeoadjuvant therapyMedicineEpidermal growth factor receptorInternal medicineCancerCancer researchHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchBreast Cancer Treatment Studies